Staff Scientist
Chemistry · Antigua and Barbuda · 2021-11-18
Proposed Endeavor
The petitioner proposes to continue developing novel organic chemical substances using synthetic organic chemistry, cheminformatics, and nanoscience. This work aims to facilitate drug discovery for critical conditions such as cancer and radiation exposure, providing robust solutions for patient recovery outcomes.
Framework Evaluation
3 of 3 criteria metThe research provides solutions for patient recovery and bypasses side effects of autoimmune treatments, benefiting U.S. public health.
The petitioner has an extensive history of 35 publications and over 5,000 citations, supported by funding from the NIH and DoD.
On balance, the petitioner's role as a critical resource in medical practice and scholarly research justifies the waiver.
Why This Petition Was Approved
Evidence
Similar Cases
Software Engineer
Artificial Intelligence · India
Management Consultant
Information Technology
Researcher
Healthcare
Others
Information Technology · China
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-11-18.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist